Guardant Health
GH
#1123
Rank
A$30.72 B
Marketcap
A$227.13
Share price
0.11%
Change (1 day)
51.58%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -A$0.67 Billion

According to Guardant Health 's latest financial reports the company's current earnings are A$1.18 Billion. In 2025 the company made an earning of -A$0.61 Billion, an increase over its 2024 earnings that were of -A$0.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.67 Billion9.78%
2025 -A$0.61 Billion-4.03%
2024 -A$0.64 Billion-9.12%
2023 -A$0.7 Billion-26.73%
2022 -A$0.96 Billion69.96%
2021 -A$0.57 Billion56.35%
2020 -A$0.36 Billion252.69%
2019 -A$0.11 Billion-17.22%
2018 -A$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-A$98.82 Million-85.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-A$0.37 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA